Cargando…

A resected case of acinar cell carcinoma of the pancreas with liver metastasis following chemotherapy using modified FOLFIRINOX

BACKGROUND: Acinar cell carcinoma of the pancreas is a rare exocrine malignancy representing less than 1% of all pancreatic neoplasms. It has been reported that it responds to treatment differently from pancreatic ductal adenocarcinoma and the treatment algorithm for acinar cell carcinoma usually de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamada, Shuhei, Motegi, Haruka, Kurihara, Yoshiki, Shimbo, Tomonori, Kikuchi, Isao, Wakabayashi, Toshiki, Sato, Tsutomu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10447704/ https://www.ncbi.nlm.nih.gov/pubmed/37610633 http://dx.doi.org/10.1186/s40792-023-01729-1

Ejemplares similares

Successful Salvage Chemotherapy with FOLFIRINOX for Recurrent Mixed Acinar Cell Carcinoma and Ductal Adenocarcinoma of the Pancreas in an Adolescent Patient
por: Pfrommer, Sarah, et al.
Publicado: (2013)

Curative resection of a primarily unresectable acinar cell carcinoma of the pancreas after chemotherapy
por: Distler, Marius, et al.
Publicado: (2009)

Acinar Cell Carcinoma of the Pancreas with Colon Involvement
por: Asayama, Naoki, et al.
Publicado: (2014)

Acinar Cell Cystadenocarcinoma of the Pancreas
por: Aoto, Keita, et al.
Publicado: (2017)

Symptomatic acinar cell cystadenoma of the pancreas
por: Sergi, William, et al.
Publicado: (2023)

Pancreatic acinar cell carcinoma presenting with panniculitis, successfully treated with FOLFIRINOX: A case report
por: Yoshihiro, Tomoyasu, et al.
Publicado: (2017)

Acinar Cell Cystadenoma (Acinar Cystic Transformation) of the Pancreas: the Radiologic-Pathologic Features
por: Gumus, Mehmet, et al.
Publicado: (2011)

A resected case of symptomatic acinar cell cystadenoma of the pancreas displacing the main pancreatic duct
por: Tanaka, Haruyoshi, et al.
Publicado: (2016)

Clinical Characteristics of Resected Acinar Cell Carcinoma of the Pancreas: A Korean Multi-Institutional Study
por: Shin, Sang Hyun, et al.
Publicado: (2021)

Analysis of the efficacy and tolerability of FOLFIRINOX chemotherapy treatment in patients over 65 years of age with diagnosis of advanced adenocarcinoma of the pancreas
por: Domagała-Haduch, Małgorzata, et al.
Publicado: (2023)

Acinar Cell Carcinoma of the Pancreas: Clinical and Cytomorphologic Characteristics
por: Toll, Adam D., et al.
Publicado: (2013)

Mixed Acinar-Neuroendocrine Carcinoma of the Pancreas with Neuroendocrine Predominance
por: Ogbonna, Onyekachi Henry, et al.
Publicado: (2013)

Induction Chemotherapy With FOLFIRINOX Followed by Chemoradiation With Gemcitabine in Patients With Borderline-Resectable Pancreatic Ductal Adenocarcinoma
por: Acuna-Villaorduna, Ana, et al.
Publicado: (2022)

Modified FOLFIRINOX for resected pancreatic cancer: Opportunities and challenges
por: Yang, Feng, et al.
Publicado: (2019)

Successful conversion surgery after FOLFIRINOX therapy in a patient with advanced pancreatic acinar cell carcinoma with a solitary peritoneal dissemination: A case report
por: Uemura, Sunao, et al.
Publicado: (2022)

Acinar cell carcinoma of rat pancreas: regulation of cholesterol esterification.
por: Rao, K. N., et al.
Publicado: (1986)

Mixed acinar-endocrine carcinoma of the pancreas--a case report.
por: Cho, K. J., et al.
Publicado: (1996)

Calcium signalling in the acinar environment of the exocrine pancreas: physiology and pathophysiology
por: Gryshchenko, Oleksiy, et al.
Publicado: (2018)

Rare case of acinar cell carcinoma with multiple lesions in the pancreas
por: Ikeda, Yuki, et al.
Publicado: (2020)

FOLFIRINOX in borderline resectable and locally advanced unresectable pancreatic adenocarcinoma
por: Yoo, Changhoon, et al.
Publicado: (2020)

Adjuvant FOLFIRINOX in Patients with Resectable Pancreatic Cancer Is Effective but Rarely Feasible in Real Life: Is Neoadjuvant FOLFIRINOX a Better Option?
por: Maman, Yossi, et al.
Publicado: (2023)

Resection of Locally Advanced Pancreatic Neoplasms after Neoadjuvant Chemotherapy with Nab-Paclitaxel and Gemcitabine following FOLFIRINOX Failure
por: Hahn, Sarah, et al.
Publicado: (2017)

Surgical and Oncological Outcomes After Preoperative FOLFIRINOX Chemotherapy in Resected Pancreatic Cancer: An International Multicenter Cohort Study
por: van Veldhuisen, Eran, et al.
Publicado: (2022)

Imaging Findings in a Case of Mixed Acinar-Endocrine Carcinoma of the Pancreas
por: Chung, Won Jung, et al.
Publicado: (2010)

PNA lectin for purifying mouse acinar cells from the inflamed pancreas
por: Xiao, Xiangwei, et al.
Publicado: (2016)

A case report of mixed acinar-endocrine carcinoma of the pancreas treated with S-1 chemotherapy: Does it work or induce endocrine differentiation?
por: Yokode, Masataka, et al.
Publicado: (2017)

Mixed acinar-endocrine carcinoma of the pancreas: a case report and review of the literature
por: Kyriazi, Maria A, et al.
Publicado: (2009)

Use of panitumumab in the treatment of acinar cell carcinoma of the pancreas: A case report
por: MORALES, MANUEL, et al.
Publicado: (2013)

Acinar Cell Carcinoma of the Pancreas: Overview of Clinicopathologic Features and Insights into the Molecular Pathology
por: La Rosa, Stefano, et al.
Publicado: (2015)

Calcium imaging in intact mouse acinar cells in acute pancreas tissue slices
por: Marolt, Urška, et al.
Publicado: (2022)

Acinar cystic transformation of the pancreas—a rare case in a young patient
por: Steinkraus, Kira Carlotta, et al.
Publicado: (2023)

Surgical resection of metastasis to the pancreas
por: You, Dong Do, et al.
Publicado: (2011)

Nab-paclitaxel and gemcitabine or FOLFIRINOX as first-line treatment in patients with unresectable adenocarcinoma of the pancreas: does sequence matter?
por: Vogl, Ursula M., et al.
Publicado: (2019)

Mixed acinar-endocrine carcinoma of pancreas: A case report and brief review of the literature
por: Liu, Zhenzhen, et al.
Publicado: (2015)

Acinar cells in the neonatal pancreas grow by self-duplication and not by neogenesis from duct cells
por: Houbracken, Isabelle, et al.
Publicado: (2017)

Orthotopic and heterotopic murine models of pancreatic cancer and their different responses to FOLFIRINOX chemotherapy
por: Erstad, Derek J., et al.
Publicado: (2018)

Hepatic Arterial Infusion Chemotherapy With Folfirinox or Oxaliplatin Alone in Metastatic Colorectal Cancer
por: Randrian, Violaine, et al.
Publicado: (2022)

Intraductal Papillary Mucinous Neoplasm of the Pancreas Arising in the Setting of an Intermixed Acinar Cell Cystadenoma of the Pancreas: Report of a Rare Case
por: Scott, Benjamin B., et al.
Publicado: (2016)

Endoscopic ultrasound in the diagnosis of acinar cell carcinoma of the pancreas: contrast-enhanced endoscopic ultrasound, endoscopic ultrasound elastography, and pathological correlation
por: Chantarojanasiri, Tanyaporn, et al.
Publicado: (2016)

Effect of FOLFIRINOX as second-line chemotherapy for metastatic pancreatic cancer after gemcitabine-based chemotherapy failure
por: Kobayashi, Noritoshi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6g9irnfklc2u8kfqsm05buf3gk